Shree Ganesh Bio-Tech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
For the nine months, sales was INR 164.94 million compared to INR 544.77 million a year ago. Revenue was INR 164.94 million compared to INR 544.58 million a year ago. Net income was INR 3.11 million compared to INR 26.18 million a year ago. Basic earnings per share from continuing operations was INR 0.01 compared to INR 0.07 a year ago. Diluted earnings per share from continuing operations was INR 0.01 compared to INR 0.07 a year ago.